Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

Gastroenterologie clinique et biologique - 1 Jan 2002

Schvoerer Evelyne, Kabissa Imed, Cotto Emmanuelle, Jouvencel Anne-Christine, Balabaud Charles, De Ledinghen Victor, Couzigou Patrice, Quinton André, Schvoerer Claire, Lafon Marie-Edith, Fleury Hervé, Bernard Pierre-Henri

Abstract excerpt

OBJECTIVE: As conflicting results have been observed by some authors in liver recipients, the aim of the study was to evaluate lamivudine therapy in 3 groups of patients with chronic hepatitis B: non-transplanted patients, liver and kidney recipients. METHODS: All patients were studied for clinical symptoms, hepatic enzymes, hepatitis B virus (HBV) serology, serum HBV DNA load, and HBV polymerase genotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Products, pol

Share to Hepatitis B virus

Share to Hepatitis C, Chronic

Share to Kidney Transplantation

Share to Lamivudine

Share to Liver Transplantation

Source

Identifiers

PMID: 11938042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.PMID 11938042Read ↗

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.Semantic proximity Read ↗

Management of hepatitis B after renal transplantation: an update.Semantic proximity Read ↗

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.Semantic proximity Read ↗

Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.Semantic proximity Read ↗

Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.Semantic proximity Read ↗

The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.Semantic proximity Read ↗

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.Semantic proximity Read ↗

[Treatment of chronic viral hepatitis B with lamivudine].Semantic proximity Read ↗

Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.Semantic proximity Read ↗

Experience with lamivudine against hepatitis B virus.Semantic proximity Read ↗

Lamivudine as initial treatment for chronic hepatitis B in the United States.Semantic proximity Read ↗

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.